| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 9 buys and 5 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $21.70M | - | |
| 10% | 5.61M | $11.79M | - | |
| CFO | 100.0K | $210.0K | - | |
| CEO | 100.0K | $210.0K | - | |
| Other | 100.0K | $210.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2019 | Freeman Kevin D56 | Director | Buy | 500 | $4.73 | $2,365.00 | +33.3% | |
| Apr 5, 2019 | Uihlein Richard E | Director, 10% Owner | Buy | 21,000 | $4.81 | $100,972.20 | +0.8% | |
| Apr 5, 2019 | Lewis Joel59 | Director | Buy | 667 | $4.82 | $3,214.07 | +1.0% | |
| Feb 22, 2019 | Rubin Marc | Director | Sale+OE | 51,185 | $6.02 | $308,201.11 | -55.7% | |
| Feb 8, 2019 | Freeman Kevin D56 | Director | Buy | 1,500 | $4.29 | $6,427.50 | New | |
| Feb 7, 2019 | Lewis Joel59 | Director | Buy | 1,000 | $4.48 | $4,484.10 | +1.6% | |
| Jan 31, 2019 | Amelio Gilbert F | Director | Sell | 30,000 | $5.00 | $150,000.00 | -8.5% | |
| Jan 29, 2019 | Lewis Joel59 | Director | Buy | 1,000 | $4.81 | $4,805.00 | +1.6% | |
| Jan 29, 2019 | Uihlein Richard E | Director, 10% Owner | Buy | 51,500 | $4.87 | $250,558.60 | +1.0% | |
| Sep 25, 2018 | Eldred Kary80 | Director | Buy | 2,000 | $6.10 | $12,199.80 | +5.1% |